-
A275977-50mgShipped at 4°C. Store at -20°C.
-
A275977-5mgShipped at 4°C. Store at -20°C.
-
A413743-100mgInformationAZD3965 AZD3965 is a potent, selective and orally available monocarboxylate transporter 1 ( MCT1 ) inhibitor with a binding affinity of 1.6 nM, 6-fold selective over MCT2. Phase 1.TargetsMCT1In vitroIn lymphoma cell lines that
-
A413743-10mgInformationAZD3965 AZD3965 is a potent, selective and orally available monocarboxylate transporter 1 ( MCT1 ) inhibitor with a binding affinity of 1.6 nM, 6-fold selective over MCT2. Phase 1.TargetsMCT1In vitroIn lymphoma cell lines that
-
A413743-1mgInformationAZD3965 AZD3965 is a potent, selective and orally available monocarboxylate transporter 1 ( MCT1 ) inhibitor with a binding affinity of 1.6 nM, 6-fold selective over MCT2. Phase 1.TargetsMCT1In vitroIn lymphoma cell lines that
-
A413743-25mgInformationAZD3965 AZD3965 is a potent, selective and orally available monocarboxylate transporter 1 ( MCT1 ) inhibitor with a binding affinity of 1.6 nM, 6-fold selective over MCT2. Phase 1.TargetsMCT1In vitroIn lymphoma cell lines that
-
A413743-50mgInformationAZD3965 AZD3965 is a potent, selective and orally available monocarboxylate transporter 1 ( MCT1 ) inhibitor with a binding affinity of 1.6 nM, 6-fold selective over MCT2. Phase 1.TargetsMCT1In vitroIn lymphoma cell lines that
-
A413743-5mgInformationAZD3965 AZD3965 is a potent, selective and orally available monocarboxylate transporter 1 ( MCT1 ) inhibitor with a binding affinity of 1.6 nM, 6-fold selective over MCT2. Phase 1.TargetsMCT1In vitroIn lymphoma cell lines that
-
-
-
-